Insights
Search Results
Client Highlights
6.11.26
Wilson Sonsini Advises Adyen on $335 Million Acquisition of Orb
On June 11, 2026, Adyen N.V. (AMS: ADYEN), a global financial technology platform, announced it has entered into a definitive agreement to acquire enterprise billing platform Orb for $335 million. Upon closing, Orb will become an indirect, wholly owned subsidiary managed under an incubator model. The strategic intent is to eventually create a unified infrastructure experience for merchants across billing and payments.
Client Highlights
3.24.26
Firm Advises Dimer Health on $13.5 Million Series A Financing
On March 23, 2026, Dimer Health, a clinician-led, AI-native transitional care medicine company, announced $13.5 million in Series A financing led by Team8 and Bill Ackman's Table Management, with participation from existing investors Silver Circle and TechAviv. The round brings the company's total funding to $20 million and will support national expansion of Dimer's dedicated post-discharge clinical service line, now operating across eight states. Wilson Sonsini Goodrich & Rosati advised Dimer on the transaction.
Client Highlights
3.24.26
Wilson Sonsini Advises Spade on $40 Million Series B
On March 24, 2026, Spade, the data and AI platform transforming how financial institutions use transaction data, announced $40 million in Series B funding. The round was led by Oak HC/FT, with participation by Andreessen Horowitz, Flourish, Gradient, NAventures, National Bank of Canada’s corporate venture arm, and Y Combinator. Wilson Sonsini Goodrich & Rosati advised Spade on the transaction.
Client Highlights
10.20.25
Wilson Sonsini Advises Lexeo Therapeutics on $153.8 Million Underwritten Public Offering and Concurrent Private Placement
On October 20, 2025, Lexeo Therapeutics, a clinical-stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced the closing of its previously announced underwritten public offering and concurrent private placement, for total gross proceeds to Lexeo of approximately $153.8 million, before deducting underwriting discounts and commissions and other expenses. Wilson Sonsini Goodrich & Rosati represented Lexeo in the transaction.
Client Highlights
6.02.25
Wilson Sonsini Advises Lexeo Therapeutics on $80 Million Private Placement Equity Financing
On May 28, 2025, Lexeo Therapeutics, a clinical-stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, closed its previously announced $80 million private placement equity financing. Wilson Sonsini Goodrich & Rosati advised Lexeo on the transaction.
Client Highlights
2.04.25
Wilson Sonsini Advises TravelPerk on $200 Million Series E Financing
On January 28, 2025, TravelPerk, a business travel platform based in Barcelona, Spain, and Zurich, Switzerland, raised $200 million in Series E funding. The oversubscribed round doubled the company's valuation to $2.7 billion. The funding was led by Atomico and EQT Growth, with participation from Noteus Partners and existing investors, including Kinnevik and General Catalyst. TravelPerk was advised by Wilson Sonsini Goodrich & Rosati during the transaction.
Client Highlights
1.28.25
Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing
On January 28, 2025, Ascentage Pharma Group International announced the closing of its U.S. initial public offering of 7,325,000 American depositary shares (ADSs) at a public offering price of $17.25 per ADS, before underwriting discounts and commissions. Each ADS represents four ordinary shares of Ascentage Pharma. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ascentage Pharma, were approximately $126.4 million. In addition, Ascentage Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,098,750 ADSs at the initial public offering price, less underwriting discounts and commissions. The ADSs began trading on the Nasdaq Global Market on January 24, 2025.
Client Highlights
10.25.24
Wilson Sonsini Represents Squarespace Founder and CEO in Close of $7.2 Billion Take-Private Transaction
On October 17, 2024, global investment firm Permira announced the completion of its funds’ previously announced acquisition of Squarespace, Inc. in an all-cash transaction that valued Squarespace at an aggregated transaction value of approximately $7.2 billion. As part of the transaction, Squarespace founder and CEO Anthony Casalena rolled over a substantial majority of his existing equity and continues to be one of the largest shareholders in the company. He continues to serve as Squarespace’s CEO and board chairman, leading the business in all aspects of its operations, along with Squarespace’s current leadership team, who have continued in their roles.
Wilson Sonsini Goodrich & Rosati represented Mr. Casalena in the transaction. The firm’s team included Marty Korman, Todd Cleary, Megan Baier, Amy Simmerman, Catherine Riley Tzipori, Derek Wallace, Carole Rosenberg, Adrian Broderick, and Ryan Hart.
For more information, please see the companies’ joint news release.
Wilson Sonsini Goodrich & Rosati represented Mr. Casalena in the transaction. The firm’s team included Marty Korman, Todd Cleary, Megan Baier, Amy Simmerman, Catherine Riley Tzipori, Derek Wallace, Carole Rosenberg, Adrian Broderick, and Ryan Hart.
For more information, please see the companies’ joint news release.
Client Highlights
10.08.24
Wilson Sonsini Advises Maven Clinic on $125 Million Series F Financing
On October 8, 2024, Maven Clinic, a NYC-based virtual clinic for women’s and family health, announced it has raised $125 million in a Series F funding round. The round, which brought the total funding to more than $425 million, was led by StepStone Group, with participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. Wilson Sonsini Goodrich & Rosati represented Maven in the transaction.
Client Highlights
9.19.24
Wilson Sonsini Advises Pie on $11.5 Million Series A
On September 18, 2024, in a Wall Street Journal exclusive, Pie, a mobile events app, revealed that it has raised $11.5 million in a Series A financing round, led by Forerunner Ventures and included participation from Ev Williams (a co-founder of Twitter and founder of Medium), Origin Ventures, and Renegade Partners, as well as longtime investor Precursor Ventures. The company has raised $24 million to date.
News Articles
8.08.24
IFLR1000 Recognizes Wilson Sonsini Practices, Attorneys in 2024 Guide
In the 2024 edition of its annual guide, IFLR recognized Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors in the U.S. and China. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
Client Highlights
8.02.24
Wilson Sonsini Advises Aurora on $483 Million Upsized Public Offering
On August 2, 2024, Aurora Innovation, Inc., a self-driving vehicle technology company, announced the closing of its underwritten upsized public offering for total gross proceeds of approximately $483 million, before deducting underwriting discounts and commissions and other offering expenses. In the public offering, Aurora sold 134,166,667 shares of its Class A common stock at $3.60 per share, which includes the full exercise by the underwriters of their option to purchase up to 17,500,000 additional shares.